Klebsiella pneumoniae is a Gram-negative pathogen responsible for community-acquired
and nosocomial infections. The strains of this species belong to the opportunistic group …

Gut microbiome alterations may play a paramount role in determining the clinical outcome of
clinical COVID-19 with underlying comorbid conditions like T2D, cardiovascular disorders …

Tigecycline is regarded as the last line of defense to combat multidrug-resistant Klebsiella
pneumoniae. However, increasing utilization has led to rising drug resistance and treatment …

The emergence of multidrug-resistant strains of Gram-negative Klebsiella species is an
urgent global threat. The World Health Organization has listed Klebsiella pneumoniae as …

Multiple sclerosis (MS) is known as a chronic inflammatory disease (CID) that affects the
central nervous system and leads to nerve demyelination. However, the exact cause of MS …

Antimicrobial resistance (AMR) is a global health and economic crisis. With too few
antibiotics in development to meet current and anticipated needs, there is a critical need for …

Introduction: Klebsiella is a clinically important pathogen causing a variety of antimicrobial
resistant infections in both community and nosocomial settings, particularly pneumonia …

The extracellular polysaccharide capsule of Klebsiella pneumoniae resists penetration by
antimicrobials and protects the bacteria from the innate immune system. Host antimicrobial …

Microbes gain access to eukaryotic cells as food for bacteria-grazing protists, for host
protection by microbe-killing immune cells, or for microbial benefit when pathogens enter …

Klebsiella pneumoniae is a common cause of human-pneumonia-derived sepsis with high
morbidity and mortality. The microbiota promotes and maintains host immune homeostasis …